Dr. Reddy's Laboratories Ltd. enters the OTC vision care with the US launch of olopatadine hydrochloride 0.2% and 0.1% ophthalmic solutions, generic equivalents of two Pataday brand eye allergy formulations approved in an OTC switch earlier this year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?